课题基金 / 基金详情

TRIAL OF REPEATED DOSES OF LJP 394 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHMATOSUS

TRIAL OF REPEATED DOSES OF LJP 394 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHMATOSUS
在系统性红斑狼疮患者中重复服用 LJP 394 的试验
批准号:
6275324
负责人:
Rosalind Ramsey-Goldman
金额:
$2.26万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

Rosalind Ramsey-Goldman的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是确定LJP 394是否更有效
英文摘要
The purpose of this study is to determine whether LJP 394 is more effective than placebo in preventing renal flare in patients with a prior history of lupus renal disease. This multicenter, double-blind, randomized, placebo- controlled study will enrol approximately 400 patients and is composed of three periods: a screening/qualifying period, a double-blind, placebo- controlled treatment period, and a follow-up assessment period. This is an 18 month trial, with patients completing 61 visits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine
  • 批准号:
    10654055
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2022
  • 负责人:
    Rosalind Ramsey-Goldman
  • 依托单位:
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine
  • 批准号:
    10510394
  • 项目类别:
  • 资助金额:
    $24.0万
  • 财政年份:
    2022
  • 负责人:
    Rosalind Ramsey-Goldman
  • 依托单位:
Cancer risk after renal transplant in autoimmune disease
  • 批准号:
    8387402
  • 项目类别:
  • 资助金额:
    $9.19万
  • 财政年份:
    2012
  • 负责人:
    Rosalind Ramsey-Goldman
  • 依托单位:
Cancer risk after renal transplant in autoimmune disease
  • 批准号:
    8507183
  • 项目类别:
  • 资助金额:
    $7.35万
  • 财政年份:
    2012
  • 负责人:
    Rosalind Ramsey-Goldman
  • 依托单位:
海外基金